Atorvastatin Calcium
Product Images NDC 53002-3439

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 53002-3439). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatin-fig-1 (Atorvastatin Fig 1)

A line graph comparing cumulative incidence percentages over time (in years) for Atorvastatin versus placebo. The graph shows Atorvastatin consistently having lower cumulative incidence than placebo, with a hazard ratio (HR) of 0.64 and p-value of 0.0005 indicated on the chart.*

FDA Label Image

Atorvastatin-fig-2 (Atorvastatin Fig 2)

A line graph comparing cumulative hazard percentages over time for Atorvastatin and placebo groups during a four-year follow-up. The graph shows time in years on the x-axis and cumulative hazard percentage on the y-axis, with Atorvastatin represented by a solid line and placebo by a dashed line, indicating lower cumulative hazard in the Atorvastatin group.*

FDA Label Image

Atorvastatin-fig-3 (Atorvastatin Fig 3)

A line graph showing the percentage of subjects experiencing an event over time, comparing Atorvastatin 10 mg and 80 mg doses. The x-axis represents time to first major cardiovascular endpoint in years (0 to 5), and the y-axis represents the percentage of subjects experiencing an event (0 to 0.2%). Two lines display event incidence for Atorvastatin 10 mg (dashed) and 80 mg (solid).*

FDA Label Image

Atorvastatin-st (Atorvastatin St)

Chemical structure of Atorvastatin Calcium showing the molecular arrangement including phenyl, fluorophenyl, and pyrrole rings, hydroxyl groups, carboxylate groups, calcium ions (Ca2+), and three water molecules (3H2O) as part of the structure.*

FDA Label Image

Label Image (Lbl530023439)

Atorvastatin Calcium 10 mg tablets label from RPK Pharmaceuticals, Inc. The label indicates a prescription medication with dosing instructions to take one tablet daily as directed. The package contains 100 tablets. It includes barcode and lot information, pharmacy and patient details on the label, along with regulatory and billing codes. The label also notes discard after 18-30-2024.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.